|Horizon||30 Days Login to change|
ResMed Inc vs. DexCom Inc
Considering 30-days investment horizon, ResMed is expected to under-perform the DexCom. But the stock apears to be less risky and, when comparing its historical volatility, ResMed is 1.7 times less risky than DexCom. The stock trades about -0.23 of its potential returns per unit of risk. The DexCom is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 13,908 in DexCom on September 19, 2018 and sell it today you would lose (1,008) from holding DexCom or give up 7.25% of portfolio value over 30 days.
Pair Corralation between ResMed and DexCom